Status:
RECRUITING
Prospective Clinical Trial on the Impact of Uterine Firomatosis on Pelvic Floor.
Lead Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions:
Pelvic Floor Dysfunction
Fibromatosis
Eligibility:
FEMALE
35-55 years
Brief Summary
Uterine fibromatosis is one of the most frequent gynecological conditions; in fact, uterine fibroids involve approximately 25-30% of women during the fertile period. Risk factors for the development o...
Eligibility Criteria
Inclusion
- Symptomatic uterine fibromatosis with intramural and/or subserosal myomas identified by ultrasound and topographically mapped
- Patients with scheduled hysterectomy or myomectomy
Exclusion
- suspicion of malignant lesion.
- active tumors
- previous history of chemotherapy or radiotherapy
- pregnancy
- age \<18 years or \>55 years (postmenopause)
- history of pelvic static disorders prior to surgery
Key Trial Info
Start Date :
June 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07180524
Start Date
June 30 2024
End Date
December 31 2029
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Policlinico San Matteo, SC Ostetricia e Ginecologia 1
Pavia, Pavia, Italy, 27100